Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Evogene stock
Learn how to easily invest in Evogene stock.
Evogene Ltd is a biotechnology business based in the US. Evogene shares (EVGN) are listed on the NASDAQ and all prices are listed in US Dollars. Evogene employs 131 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Evogene
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EVGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Evogene stock price (NASDAQ: EVGN)Use our graph to track the performance of EVGN stocks over time.
Evogene shares at a glance
|Latest market close||$1.57|
|52-week range||$1.50 - $10.24|
|50-day moving average||$2.08|
|200-day moving average||$3.03|
|Wall St. target price||$12.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.74|
Buy Evogene shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Evogene stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evogene price performance over time
|1 week (2022-01-07)||-2.48%|
|1 month (2021-12-15)||-13.74%|
|3 months (2021-10-15)||-41.42%|
|6 months (2021-07-16)||-47.84%|
|1 year (2021-01-15)||-74.18%|
|2 years (2020-01-16)||-7.92%|
|3 years (2019-01-15)||2.0963|
|5 years (2017-01-12)||5.53|
|Gross profit TTM||$466,000|
|Return on assets TTM||-24.63%|
|Return on equity TTM||-49.08%|
|Market capitalisation||$67.4 million|
TTM: trailing 12 months
Evogene share dividends
We're not expecting Evogene to pay a dividend over the next 12 months.
Have Evogene's shares ever split?
Evogene's shares were split on a 1:2 basis on 18 November 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evogene shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Evogene shares which in turn could have impacted Evogene's share price.
Evogene share price volatility
Over the last 12 months, Evogene's shares have ranged in value from as little as $1.5 up to $10.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evogene's is 0.8389. This would suggest that Evogene's shares are less volatile than average (for this exchange).
Evogene Ltd. , together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton.
Evogene in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128 in Combination with Bristol Myers Squibb's Anti-PD-1 Opdivo®
Frequently asked questionsWhat percentage of Evogene is owned by insiders or institutions?
Currently 6.225% of Evogene shares are held by insiders and 15.71% by institutions. How many people work for Evogene?
Latest data suggests 131 work at Evogene. When does the fiscal year end for Evogene?
Evogene's fiscal year ends in December. Where is Evogene based?
Evogene's address is: 13 Gad Feinstein Street, Rehovot, Israel, 7414002 What is Evogene's ISIN number?
Evogene's international securities identification number is: IL0011050551 What is Evogene's CUSIP number?
Evogene's Committee on Uniform Securities Identification Procedures number is: M4119S104
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert